IVF Over 40: What SART Success Rate Numbers Mean For Your Journey

If you are considering IVF at 40 or older, you have probably searched for success rates countless times. Which number applies to you? The honest answer is: it depends on what metric you are looking at.

IVF success is not one single number. Results differ based on whether you review one egg-retrieval cycle or multiple cycles, whether you use your own eggs versus donor eggs, and most critically, your personal ovarian reserve.

One Cycle: The Numbers You Need to Know

The SART 2024 National Summary Report aggregates real-world data across U.S. SART-member clinics, covering more than 430 000 IVF cycles. Live-birth rates per intended egg retrieval drop sharply with advancing age:

These figures show the probability of achieving a live birth from each egg-retrieval cycle you start. Minor numerical differences appear across different datasets and reporting years, yet the trend is clear: success rates drop far more rapidly once you turn 40.

Cumulative Success: The Metric That Reflects Your Full IVF Journey

Single-cycle statistics can feel discouraging. But most women over 40 do not stop after just one attempt. Cumulative live-birth rate estimates your odds of delivering a baby after completing multiple egg retrieval cycles.

SART hosts an online calculator to project cumulative outcomes across up to three full IVF cycles (egg retrieval plus transfers of all resulting embryos).

Real-world baseline data from the SART prediction tool for patients using their own eggs:

For patients aged 41-42, the per retrieval live-birth rate sits below 10%, yet cumulative odds rise to roughly 19% across multiple cycles.

For women over 42, cumulative live-birth rates reach approximately 10%. These population-level figures reflect average outcomes for all patients seeking treatment.

Selected study cohorts with more favorable patient profiles

Selected study cohorts with more favorable patient profiles report higher numbers which do not apply universally to everyone.

One research example published in Fertility and Sterility follows a 40-year-old patient with AMH = 1 ng/mL: she saw a 26.2% live-birth chance in her first full cycle, rising to 39.2% across three complete cycles.

Separate research has observed that for selected 41-42-year-old study participants, cumulative live-birth rates reached 59.9% with PGT-A, compared to 29.7% without genetic screening.

This highlights the potential benefit of embryo genetic testing in this age bracket, though these results come from a filtered study population and will not be typical for all patients.

Key takeaway: A single-cycle rate describes one attempt; cumulative rates describe your full treatment journey. 

Why Age Impacts IVF Success So Strongly?

Two core driving factors are egg quantity and egg quality.

1. Egg quantity: Ovarian reserve (measured via AMH and antral follicle count) decreases yearoveryear with age. Fewer eggs are retrieved with each stimulation cycle.

2. Egg quality: Chromosome abnormality rates in eggs rise substantially as women get older.

ASRM’s 2026 Recurrent Implantation Failure guideline confirms that agerelated aneuploidy (chromosomal errors) is the leading cause of implantation failure for older patients.

This makes PGT-A especially valuable for people over 40: it helps identify chromosomally normal embryos with higher implantation potential.

Still, there is a real practical limitation. Patients with diminished ovarian reserve may produce very few blastocysts for testing. Sometimes no embryos reach the blastocyst stage at all, making PGT-A not feasible.

For older women, treatment planning often balances two goals: maximizing egg quantity versus maximizing egg quality.

Protocol Choices: No “One-Size-Fits-All” IVF Plan

There is no universally “best” stimulation protocol for women of advanced maternal age. Treatment plans are tailored to your AMH, antral follicle count, prior IVF history, and body response. 

Common options:

1. Conventional / Antagonist Protocol: For reasonable ovarian reserve, aims for higher egg yield.

2. Microdose Flare Protocol: Considered for poor responders who did not respond well to standard protocols.

3. Mini-IVF (Minimal Stimulation): Lower-dose drugs, prioritizes egg quality over quantity; ideal for low AMH.

4. Natural-cycle IVF: No medication; for very low ovarian response, retrieving only 1-2 eggs per cycle.

The Emotional Reality of IVF Over 40

The emotional toll of IVF at advanced maternal age is frequently underestimated. It is completely normal to feel anxious, burnt out or frustrated.

Seeking support from therapists, peer communities or your partner is not a sign of weakness. Many patients benefit from mental-health support alongside medical treatment.

Better Questions to Ask Instead of “What Are My Odds?”

Many women see low single-cycle success percentages and feel ready to give up. Reframe your thinking with these three practical questions:

1. How many cycles can I realistically commit to? IVF for older patients often unfolds over multiple cycles; one retrieval rarely tells the whole story.

2. What do my ovarian-reserve tests (AMH, AFC) show? These results heavily guide your protocol selection.

3. What kind of psychological expectations should be set? This is the emotional management that must be done well for elderly people undergoing IVF

The Bottom Line

IVF over 40 is statistically harder than IVF under 35, but harder does not equal hopeless. Population-level SART data puts the multi-cycle cumulative live birth rate at 19% for this age group. Selected study subgroups can show higher outcomes.

Understand which statistics apply to your unique profile, collaborate with your fertility provider to build a personalized plan, and plan for the full journey; not just one transfer attempt.

This path may take longer than you hoped, but positive outcomes remain possible.

Have questions about planning IVF as an older patient? Connect with the CEF team for educational resources. Email info@cefivf.com or visit our Contact page.

Disclaimer: This educational article summarizes data from the SART 2024 National Summary Report, SART online cumulative success calculator, and peerreviewed publications including Fertility and Sterility. It is not personalized medical advice.

Always consult a licensed reproductiveendocrinology specialist for your individual IVF treatment plan.